Omega Therapeutics (OMGAQ) Insider Trading & Ownership $0.0030 0.00 (0.00%) As of 08/11/2025 Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Omega Therapeutics (OTCMKTS:OMGAQ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$19.21MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$320K Get OMGAQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Omega Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OMGAQ Insider Buying and Selling by Quarter Omega Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/1/2023Richard A YoungDirectorSell5,000$8.00$40,000.00 4/6/2023Richard A YoungDirectorSell5,000$8.00$40,000.00 3/17/2023Richard A YoungDirectorSell10,000$8.00$80,000.00 2/27/2023Flagship Pioneering Inc.Major ShareholderBuy3,323,310$5.78$19,208,731.80 1/10/2023Richard A YoungDirectorSell20,000$8.00$160,000.00 (Data available from 1/1/2013 forward) OMGAQ Insider Trading Activity - Frequently Asked Questions Who is on Omega Therapeutics' Insider Roster? The list of insiders at Omega Therapeutics includes Flagship Pioneering Inc., and Richard A Young. Learn more on insiders at OMGAQ. What percentage of Omega Therapeutics stock is owned by insiders? 8.50% of Omega Therapeutics stock is owned by insiders. Learn more on OMGAQ's insider holdings. Omega Therapeutics Key ExecutivesMr. Mahesh Karande (Age 50)President, CEO & Board Director Compensation: $910.39kMr. Joshua Reed M.B.A. (Age 51)Chief Financial Officer Compensation: $659.39kDr. Yan Moore M.D. (Age 57)Chief Medical Officer Compensation: $738.34kDr. Thomas McCauley Ph.D. (Age 55)Chief Scientific Officer Compensation: $588.5kMs. Ling Zeng Esq. (Age 55)J.D., Chief Legal & Administrative Officer and Secretary Compensation: $519.36kMr. Anthony MullinChief People OfficerMs. Barbara Y. Chan (Age 60)Senior Vice President of Finance Mr. Charles O'Donnell Ph.D.VP and Head of Computational Genomics & Data Sciences More Insider Trading Tools from MarketBeat Related Companies Hepion Pharmaceuticals Insider Buying Panbela Therapeutics Insider Buying Vincerx Pharma Insider Buying Smart for Life Insider Buying Evelo Biosciences Insider Buying Ampio Pharmaceuticals Insider Buying Comera Life Sciences Insider Buying Syros Pharmaceuticals Insider Buying Clever Leaves Insider Buying eFFECTOR Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (OTCMKTS:OMGAQ) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredWhy This Titanium Explorer Caught Rio Tinto’s EyeAs U.S. defense spending crosses $1 trillion, drones, hypersonics, and next-gen aerospace are taking center st...Capital Trends | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
